Header Logo

Connection

Robert Weinstein to Drug Resistance, Microbial

This is a "connection" page, showing publications Robert Weinstein has written about Drug Resistance, Microbial.
Connection Strength

2.625
  1. Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA. Emerg Infect Dis. 2015 Oct; 21(10):1725-32.
    View in: PubMed
    Score: 0.509
  2. Pharmacists' perceptions of the effectiveness of antimicrobial control programs. Am J Health Syst Pharm. 2006 Dec 15; 63(24):2504-8.
    View in: PubMed
    Score: 0.277
  3. Development of a clinical data warehouse for hospital infection control. J Am Med Inform Assoc. 2003 Sep-Oct; 10(5):454-62.
    View in: PubMed
    Score: 0.217
  4. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001 Mar-Apr; 7(2):188-92.
    View in: PubMed
    Score: 0.185
  5. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999 Feb 10; 281(6):517-23.
    View in: PubMed
    Score: 0.161
  6. Vancomycin-resistant enterococci: implications for surgeons. Surgery. 1999 Feb; 125(2):121-5.
    View in: PubMed
    Score: 0.160
  7. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med. 1998 Dec; 26(12):2001-4.
    View in: PubMed
    Score: 0.158
  8. Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis. 1998 Feb; 177(2):378-82.
    View in: PubMed
    Score: 0.150
  9. Resistant bacteria and infection control in the nursing home and hospital. Bull N Y Acad Med. 1987 Apr; 63(3):337-44.
    View in: PubMed
    Score: 0.071
  10. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc. 2001 Mar; 49(3):270-6.
    View in: PubMed
    Score: 0.046
  11. Infection control in intensive care units and prevention of ventilator-associated pneumonia. Semin Respir Infect. 2000 Dec; 15(4):327-35.
    View in: PubMed
    Score: 0.046
  12. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis. 1980 Mar; 141(3):338-45.
    View in: PubMed
    Score: 0.043
  13. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A. 1999 Jun 08; 96(12):6908-13.
    View in: PubMed
    Score: 0.041
  14. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998 May 25; 158(10):1127-32.
    View in: PubMed
    Score: 0.038
  15. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am. 1997 Jun; 11(2):479-96.
    View in: PubMed
    Score: 0.036
  16. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis. 1997 Apr; 24(4):704-6.
    View in: PubMed
    Score: 0.035
  17. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis. 1996 Oct; 23(4):779-84.
    View in: PubMed
    Score: 0.034
  18. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996 Sep 15; 125(6):448-56.
    View in: PubMed
    Score: 0.034
  19. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis. 1996 Sep; 174(3):529-36.
    View in: PubMed
    Score: 0.034
  20. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci. Chemotherapy. 1996 Jul-Aug; 42(4):235-9.
    View in: PubMed
    Score: 0.034
  21. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol. 1996 Apr; 17(4):236-48.
    View in: PubMed
    Score: 0.033
  22. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA. 1996 Jan 17; 275(3):234-40.
    View in: PubMed
    Score: 0.032
  23. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis. 1995 Apr; 20(4):861-7.
    View in: PubMed
    Score: 0.031
  24. In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann Intern Med. 1992 Sep 15; 117(6):457-60.
    View in: PubMed
    Score: 0.026
  25. Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis. 1990 Dec; 162(6):1393-7.
    View in: PubMed
    Score: 0.023
  26. Selective intestinal decontamination--an infection control measure whose time has come? Ann Intern Med. 1989 Jun 01; 110(11):853-5.
    View in: PubMed
    Score: 0.021
  27. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Chemioterapia. 1987 Oct; 6(5):315-8.
    View in: PubMed
    Score: 0.018
  28. Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control. 1986 Feb; 7(2 Suppl):120-3.
    View in: PubMed
    Score: 0.016
  29. Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients. Chemioterapia. 1985 Feb; 4(1):110-2.
    View in: PubMed
    Score: 0.015
  30. Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids. J Infect Dis. 1982 Mar; 145(3):374-82.
    View in: PubMed
    Score: 0.012
  31. Comparative in-vivo activity of Sch 29482 and six other extended spectrum cephalosporins. J Antimicrob Chemother. 1982 Feb; 9 Suppl C:41-8.
    View in: PubMed
    Score: 0.012
  32. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med. 1981 Feb; 70(2):449-54.
    View in: PubMed
    Score: 0.012
  33. Reality check: how should we control antimicrobial use? Current practices and controversies. Infect Control Hosp Epidemiol. 2000 Dec; 21(12):792-5.
    View in: PubMed
    Score: 0.011
  34. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis. 1999 Jan; 179(1):163-71.
    View in: PubMed
    Score: 0.010
  35. Coisolation of Streptococcus pneumoniae and Hameophilus influenzae from middle ear fluid and sputum: effect on MIC results. J Clin Microbiol. 1999 Jan; 37(1):277.
    View in: PubMed
    Score: 0.010
  36. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother. 1993 Sep; 37(9):1989-92.
    View in: PubMed
    Score: 0.007
  37. Infections with gram-negative bacilli in a cardiac surgery intensive care unit: the relative role of enterobacter. J Hosp Infect. 1988 Feb; 11 Suppl A:367-73.
    View in: PubMed
    Score: 0.005
  38. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med. 1985 Oct; 145(10):1804-7.
    View in: PubMed
    Score: 0.004
  39. Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis. 1985 Oct; 152(4):769-74.
    View in: PubMed
    Score: 0.004
  40. Cefoxitin disc induction of latamoxef (moxalactam) resistance. J Antimicrob Chemother. 1983 Nov; 12(5):524-5.
    View in: PubMed
    Score: 0.003
  41. Control of aminoglycoside resistance by barrier precautions. Infect Control. 1983 Jul-Aug; 4(4):221-4.
    View in: PubMed
    Score: 0.003
  42. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother. 1983 Apr; 11(4):299-310.
    View in: PubMed
    Score: 0.003
  43. Failure of Chloroquine prophylaxis in Plasmodium falciparum from East Africa. JAMA. 1981 Aug 28; 246(9):979-80.
    View in: PubMed
    Score: 0.003
  44. Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis. 1976 Mar; 133(3):363-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.